Outside experts had been set to meet next week and make a recommendation on whether to authorize two doses of the vaccine in young children. The results from Pfizer's clinical trial were mixed, leading some experts to argue that the evidence showing a benefit from two shots was not convincing
You received this email because you signed up for NYTimes.com's Breaking News Alerts.To stop receiving these emails, unsubscribe or manage your email preferences.
No comments:
Post a Comment